Results for this period
Third quarter1 January 2026 to 30 September 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in Millions of yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Steady execution of orders already received, increased shipments of aircraft components, productivity improvements including production automation, increased overseas sales, the effect of higher sales, the impact of yen depreciation, and recognition of approximately ¥2.2 billion in profit from the liquidation of an overseas subsidiary
None
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026 to 30 September 2026 |
| Net Sales | 177,885 Millions of yen (YoY +16.8%) |
| Operating profit | 14,019 Millions of yen (YoY +70.7%) |
| Ordinary income | 14,231 Millions of yen (YoY +78.2%) |
| Profit attributable to owners of the parent | 11,609 Millions of yen (YoY +58.3%) |
| Net income per share | ¥177.72 |
| Operating Margin | 7.9％ |
| Equity ratio | End of the current fiscal period 44.5％ / End of previous period 44.2％ |
| Total assets | 375,439 Millions of yen |
| Net assets | 168,985 Millions of yen |
| Cash flows from operating activities | 6,677 Millions of yen |
| Cash flows from investing activities | -8,441 Millions of yen |
| Cash flows from financing activities | -1,812 Millions of yen |
| Cash and cash equivalents at end of period | 40,853 Millions of yen |
| Full-year earnings forecast | Net Sales 247,700 Millions of yen (YoY +14.9%) / Operating profit 19,700 Millions of yen (YoY +28.5%) / Ordinary income 20,000 Millions of yen (YoY +15.9%) / Net income 15,800 Millions of yen (YoY +15.7%) |
| Revision to Earnings Forecast | No revision |
| Annual Dividend Forecast | 40 Yen → 60 Yen（+50.0%） |
| Segment revenue | Industrial business 118,447 Millions of yen (YoY +23.2%), Medical business 59,465 Millions of yen (YoY +5.6%) |
| Segment profit | Industrial business 9,918 Millions of yen (YoY +36.7%), Medical business 4,903 Millions of yen (YoY +29.6%) |
| Orders received and order backlog | Orders received 202,307 Millions of yen (YoY +23.5%) / Order backlog Not disclosed |
| Depreciation and amortization | 8,897 Millions of yen |
| Impairment loss | None recorded (impairment loss or reversal: —) |
| Breakdown of extraordinary income (loss) | Extraordinary income Item Gain on liquidation of an affiliate (other income) / Amount 2,213 Millions of yen / Extraordinary loss Not disclosed |
| Disclosure regarding the going concern assumption | None |
| Change in accounting policy | Changes due to revisions to standards None / Other changes None / Change in accounting estimate None / Restatement Not disclosed |
| Changes in the scope of consolidation | Added: 0 companies; excluded: 0 companies (not applicable) |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No (target audience: Not disclosed) |
| Issued Shares at Period-End | 69,175,664 shares |
| Treasury Shares at Period-End | 3,822,941 shares |
| Factors Behind Changes in Business Performance | Steady execution of orders already received, increased shipments of aircraft components, productivity improvements including production automation, increased overseas sales, the effect of higher sales, the impact of yen depreciation, and recognition of approximately ¥2.2 billion in profit from the liquidation of an overseas subsidiary |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Steady progress in executing orders already received for liquefied-gas and industrial-gas-related equipment and other products, increased shipments of aircraft components and improved productivity, higher sales in the medical business, particularly in overseas markets, and the recognition of approximately ¥2.2 billion in profit from the liquidation of an overseas subsidiary.